Long-Term Follow-Up Assessment of a Phase 1 Trial of Angiogenic Gene Therapy Using Direct Intramyocardial Administration of an Adenoviral Vector Expressing the VEGF121 cDNA for the Treatment of Diffuse Coronary Artery Disease-Reference-Cited by-同舟云学术

Long-Term Follow-Up Assessment of a Phase 1 Trial of Angiogenic Gene Therapy Using Direct Intramyocardial Administration of an Adenoviral Vector Expressing the VEGF121 cDNA for the Treatment of Diffuse Coronary Artery Disease

Published:2013-02 Issue:2 Volume:24 Page:203-208
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Rosengart Todd K.¹,Bishawi Muath M.¹,Halbreiner Michael S.¹,Fakhoury Mathew¹,Finnin Eileen¹,Hollmann Charleen²,Shroyer Annie Laurie¹,Crystal Ronald G.²

Affiliation:

1. Division of Cardiothoracic Surgery, Department of Surgery, Stony Brook University Medical Center, Stony Brook, NY 11794.

2. Department of Genetic Medicine, Weill Cornell Medical College, New York, NY 10065.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2012.137

Reference27 articles.

1. Transmyocardial revascularization: 5-year follow-up of a prospective, randomized multicenter trial

2. Angiogenesis in health and disease